Drug-Eluting Balloon Market Top Players- Medtronic plc, Becton, Dickinson and Company, Boston Scientific Corporation

According to The Insight Partners market research study titled ‘Drug-Eluting Balloon Market to 2027 – Global Analysis and Forecasts by Product Type, End User and Geography. The global drug-eluting balloon market is expected to reach US$ 1,870.60 Mn in 2027 from US$ 516.65Mn in 2018. The market is estimated to grow with a CAGR of 15.6% from 2019-2027. The report highlights trend prevalent in the global drug-eluting balloon market and the factors driving the market along with those that act as challenges to its growth.
Request Sample Copy Of this Report @ http://bit.ly/3rwkfY4

The List of Companies
1. Koninklijke Philips N.V.
2. Concept Medical Inc.
3. Opto Circuits (India) Limited (Eurocor Tech GmbH)
4. Terumo Corporation
5. BIOTRONIK SE & Co. KG
6. Innvolution Healthcare Pvt. Ltd.
7. Medtronic Plc
8. BD
9. Boston Scientific Corporation
10. Cook Medical
11. B. Braun Melsungen AG

The global drug-eluting balloon market is segmented on the basis of product type and end-user. The market based on product type segment is classified as coronary drug-eluting balloons, peripheral drug-eluting balloons, and other product types. Based on the end-user the market is segmented as hospitals, Cath labs & cardiac centers, and ambulatory surgical centers.

The key factors accounting for the growth of the drug-eluting balloon market include a significant increase in vascular disease incidences, growing product innovations, and rising geriatric population. Whereas, the market is expected to have slow growth due to the high cost of procedures and products and stringent regulations for approval during the forecast period.


Drug-Eluting Balloon – MARKET SEGMENTATION
Global Drug-Eluting Balloon Market – By Product Type
• Coronary Drug-Eluting Balloons
• Peripheral Drug-Eluting Balloons
• Other Product Types

Global Drug-eluting balloon Market – By End User
• Hospitals
• Cath Labs & Cardiac Centers
• Ambulatory Surgical Centers

Purchase Copy of this Report @ https://bit.ly/38xCdk8

Strategic Insights
Organic and inorganic growth strategies were observed in the global drug-eluting balloon industry. Whereas, organic growth strategies were carried out largely in the drug-eluting balloon market. For instance, in December 2019, Philips has launched two new balloons to its Stellarex 0.035” low-dose drug-coated balloon (DCB) portfolio for the treatment of de novo and restenotic lesions in native superficial femoral or popliteal arteries, both arteries in the upper leg. Thus, expansion of the product portfolio is enabling to grow the company’s offering in the drug-eluting balloons and further enabling to grow its position in the global market.

Contact:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.